journal article·2019-03

A Hybrid Nanovector of Suicide Gene Engineered Lentivirus Coated with Bioreducible Polyaminoglycosides for Enhancing Therapeutic Efficacy against Glioma

Wenhua Fan, Meiyu Shao, Junwen Zhang, Guishan Jin, Fusheng Liu, Fu‐Jian Xu

Advanced Functional Materials· Volume 29· Issue 11
Publisher page

Abstract

Abstract An emerging hybrid nanovector integrating the merits of both viral and nonviral vectors has attracted much attention as the next generation of promising gene vectors to overcome the primary challenge of cancer gene therapy. Due to its inherent advantages, lentivirus (Lv) has been increasingly applied and investigated in medical fields. Herein, a new hybrid nanovector (SS‐HPT/Lv) composed of the Lv core and reduction‐responsive hyperbranched polyaminoglycoside (SS‐HPT) shell is designed via electrostatic interaction. In comparison with polybrene (commercial enhanced transfection reagent), SS‐HPT endows the hybrid nanovector with better biosafety. Furthermore, both the appropriate nanoparticle sizes and positive surface potentials contribute to the endocytosis and rescue of SS‐HPT/Lv from endocytic vesicles. Regarding therapeutic application, lentiviral vector acquires permanent transgene expression with the capability of integrating to the host chromosome, and SS‐HPT/Lv exhibits an improved transduction efficacy. The cytosine deaminase/5‐fluorocytosine suicide gene therapy system mediated by SS‐HPT/Lv performs an enhanced antitumor efficiency and extends the survival time of glioma‐bearing rats. Such a hybrid nanovector strategy would open a new avenue to the development of gene vectors for treating malignant cancers.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: RNA Interference and Gene Delivery · Virus-based gene therapy research · Advanced biosensing and bioanalysis techniques

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Brain Tumor Research Center Beijing Neurosurgical Institute Capital Medical University and Department of Neurosurgery Beijing Tiantan Hospital Affiliated to Capital Medical University Beijing Laboratory of Biomedical Materials Beijing 100050 P. R. China

Key Laboratory of Carbon Fiber and Functional Polymers (Beijing University of Chemical Technology) Ministry of Education Beijing Laboratory of Biomedical Materials Beijing Advanced Innovation Center for Soft Matter Science and Engineering Beijing University of Chemical Technology Beijing 100029 P. R. China

Funding

Natural Science Foundation of Beijing Municipality · National Natural Science Foundation of China

References (59)

Show source-provided references
1. 10.1093/neuonc/nox15810.1093/neuonc/nox158 ↗
2. 10.1056/NEJMoa04333010.1056/NEJMoa043330 ↗
3. 10.1016/S1470-2045(03)01139-210.1016/S1470-2045(03)01139-2 ↗
4. 10.1002/adfm.20160304110.1002/adfm.201603041 ↗
5. 10.1016/j.biomaterials.2016.11.05510.1016/j.biomaterials.2016.11.055 ↗
6. 10.1002/smll.20170315210.1002/smll.201703152 ↗
7. 10.1126/science.849353010.1126/science.8493530 ↗
8. 10.1038/nrg106610.1038/nrg1066 ↗
9. 10.1146/annurev-bioeng-071813-10493810.1146/annurev-bioeng-071813-104938 ↗
10. 10.1021/acs.accounts.6b0047710.1021/acs.accounts.6b00477 ↗
11. 10.1016/j.progpolymsci.2017.09.00310.1016/j.progpolymsci.2017.09.003 ↗
12. 10.1038/nrg376310.1038/nrg3763 ↗
13. 10.1002/jgm.301110.1002/jgm.3011 ↗
14. 10.1016/j.biomaterials.2014.03.06010.1016/j.biomaterials.2014.03.060 ↗
15. 10.1016/j.bbrc.2014.03.14210.1016/j.bbrc.2014.03.142 ↗
16. 10.1021/acsnano.6b0618210.1021/acsnano.6b06182 ↗
17. 10.1016/j.biomaterials.2009.11.04310.1016/j.biomaterials.2009.11.043 ↗
18. 10.1016/j.jconrel.2010.01.03110.1016/j.jconrel.2010.01.031 ↗
19. 10.1021/acsnano.6b0415510.1021/acsnano.6b04155 ↗
20. 10.1007/s00005-010-0063-410.1007/s00005-010-0063-4 ↗
21. 10.3390/v302013210.3390/v3020132 ↗
22. 10.1089/hgtb.2017.08410.1089/hgtb.2017.084 ↗
23. Buchschacher Gl. · Blood · 2000 · 95 · 249910.1182/blood.V95.8.2499.008k35_2499_2504 ↗
24. 10.1056/NEJMoa170534210.1056/NEJMoa1705342 ↗
25. 10.15252/emmm.20150586910.15252/emmm.201505869 ↗
26. 10.1073/pnas.93.21.1138210.1073/pnas.93.21.11382 ↗
27. 10.1006/exnr.1999.717810.1006/exnr.1999.7178 ↗
28. 10.1093/neuonc/now08910.1093/neuonc/now089 ↗
29. 10.1016/j.canlet.2013.01.04810.1016/j.canlet.2013.01.048 ↗
30. 10.1073/pnas.91.17.830210.1073/pnas.91.17.8302 ↗
31. Hlavaty J. · Neoplasma · 1999 · 46 · 267
32. 10.1007/s00432-012-1347-310.1007/s00432-012-1347-3 ↗
33. Nishiyama T. · Cancer Res. · 1985 · 45 · 1753
34. Edson R. S. · Mayo Clin. Proc. · 1983 · 58 · 99
35. 10.1021/bc300016b10.1021/bc300016b ↗
36. 10.1016/j.biomaterials.2016.08.02510.1016/j.biomaterials.2016.08.025 ↗
37. 10.1002/adma.20180157010.1002/adma.201801570 ↗
38. 10.1021/acs.nanolett.8b0192410.1021/acs.nanolett.8b01924 ↗
39. Kuppusamy P. · Cancer Res. · 2002 · 62 · 307
40. 10.1002/adma.20130459210.1002/adma.201304592 ↗
41. 10.1002/adma.20130092910.1002/adma.201300929 ↗
42. 10.1016/j.biomaterials.2010.07.06710.1016/j.biomaterials.2010.07.067 ↗
43. 10.1016/j.jconrel.2011.04.01610.1016/j.jconrel.2011.04.016 ↗
44. 10.1021/la202101q10.1021/la202101q ↗
45. Lillehei C. W. · Ann. Surg. · 1960 · 151 · 11
46. 10.1073/pnas.121444111010.1073/pnas.1214441110 ↗
47. 10.1074/jbc.M117.80209010.1074/jbc.M117.802090 ↗
48. 10.1021/mp300293n10.1021/mp300293n ↗
49. 10.1128/JVI.78.6.3089-3098.200410.1128/JVI.78.6.3089-3098.2004 ↗
50. 10.7150/thno.1619210.7150/thno.16192 ↗
51. 10.1084/jem.174.4.88110.1084/jem.174.4.881 ↗
52. 10.1371/journal.ppat.100450210.1371/journal.ppat.1004502 ↗
53. 10.1074/jbc.M110.16846810.1074/jbc.M110.168468 ↗
54. 10.1038/sj.cgt.770008610.1038/sj.cgt.7700086 ↗
55. 10.1002/(SICI)1097-0215(19970516)71:4<675::AID-IJC26>3.0.CO;2-910.1002/(SICI)1097-0215(19970516)71:4<675::AID-IJC26>3.0.CO;2-9 ↗
56. 10.1016/j.canlet.2018.01.03510.1016/j.canlet.2018.01.035 ↗
57. 10.1016/j.cell.2007.05.00310.1016/j.cell.2007.05.003 ↗
58. 10.1023/B:NEON.0000013494.98345.8010.1023/B:NEON.0000013494.98345.80 ↗
59. 10.1038/sj.onc.120829010.1038/sj.onc.1208290 ↗